Citron research Highlights rare Long play

Posted by Steve Kanaval | Feb 20, 2020 | Pharmaceutical, Public Companies, Trading

Citron Research posted a rare long side play…

Schrodinger (SDGR) – Taking Drug Discovery to the “Space Age”

The Most Important IPO in the Past 5 Years

It has been almost 10 years since Tesla went public as the once “Concept Company” has since succeeded in disrupting the transportation industry and has forever changed the performance and commercial acceptance of electric vehicles. While it has been a bumpy road, the stock is now trading at parabolic levels while investors must ask themselves – What stock has the characteristics of Tesla in its early days? The answer is clear – Wall Street’s recent IPO, Schrodinger (SDGR).

Learn more about Citron Research here, we are not compensated, nor do we have any position long or short in this stock. We are not affiliated with Citron, just relaying one of their recent reports.

Post Views: 781

About The Author

Steve Kanaval

Steve Kanaval is a Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80's. He ran the Morgan Stanley Derivative Prop Trading and continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet boom of the '90s. His work is published on multiple sites including Bloomberg, MarketNewsFirst, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging-market assets.

2 Comments

What Is Pranayama? on at 11:36 am

nice blog thanks for the information
Reply
- Josh Lankford on at 11:37 pm
  
  Thanks for reading. We do it for you. Be Truly Informed, MN1.com
  Reply